Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:2146-2152
Published online before print April 21, 2003, doi: 10.1161/01.CIR.0000062686.72615.9B
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/16/2146    most recent
01.CIR.0000062686.72615.9Bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McConville, P.
Right arrow Articles by Spencer, R. G.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McConville, P.
Right arrow Articles by Spencer, R. G.S.
Related Collections
Right arrow Contractile function
Right arrow Biochemistry and metabolism
Right arrow Cardiovascular Pharmacology
Right arrow Other diagnostic testing

(Circulation. 2003;107:2146.)
© 2003 American Heart Association, Inc.


Basic Science Reports

Differences in the Bioenergetic Response of the Isolated Perfused Rat Heart to Selective ß1- and ß2-Adrenergic Receptor Stimulation

Patrick McConville, PhD; Kenneth W. Fishbein, PhD; Edward G. Lakatta, MD; Richard G.S. Spencer, PhD, MD

From the NMR Unit, Laboratory of Clinical Investigation (P.M., K.W.F., R.G.S.S.), and Laboratory for Cardiovascular Science (P.M., E.G.L.), Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Md.

Correspondence to Dr Richard Spencer, NMR Unit, GRC, National Institute on Aging/NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224. E-mail spencer{at}helix.nih.gov


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— In the heart, striking functional differences exist after stimulation of the ß1- and ß2-adrenergic receptor (AR) subtypes. These may be linked to differences in metabolic response during ß1- and ß2-AR stimulation.

Methods and Results— The relation between work and metabolism was examined during selective ß1- and ß2-AR stimulation (ß1 and ß2 groups, respectively) in the isolated perfused rat heart. Measurements were made of rate-pressure product (RPP=LV developed pressure x heart rate), phosphorus-containing metabolites, and pH by 31P nuclear magnetic resonance spectroscopy and of O2 consumption by fiber-optic oximetry. Experiments were performed under high constant flow (HCF) and under flow-limiting conditions (constant pressure, CP). Despite substantially greater RPP increases relative to baseline during ß1-AR (HCF, 475%; CP, 150%) than ß2-AR (HCF, 90%; CP, 72%) stimulation, the relative decrease in the intracellular energy charge relative to baseline was similar for the ß1 (HCF, 49%; CP, 64%) and ß2 (HCF, 59%; CP, 55%) groups. For each group, an increase in oxygen consumption (M{image}O2) occurred commensurate with workload during HCF (ß1, 141%; ß2, 30%). During CP, however, the M{image}O2 increase was similar (ß1, 39%; ß2, 34%), despite the large RPP difference between the groups. During both protocols, there was greater acidosis during ß1-AR than during ß2-AR stimulation. Thus, at a given workload, intracellular energy charge decreased, and M{image}O2 (CP) increased to a greater extent during ß2 than ß1-AR stimulation.

Conclusions— The bioenergetic differences are consistent with access to an additional substrate pool during ß1-AR stimulation. This may occur via increased glycogenolysis during ß1-AR stimulation, facilitating increased energy production by oxidative phosphorylation, and under flow-limiting conditions, anaerobic glycolysis.


Key Words: receptors, adrenergic, beta • metabolism • oxygen • imaging


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Beta-adrenergic receptors (ß-ARs) modulate the contractile response of the heart to stress. Although the importance of both the ß1- and ß2-AR subtypes has been recognized, there are substantial differences between ß1- and ß2-AR–mediated functional responses.1–4

A recent study using canines found that cAMP signaling was coupled to PKA activation during ß1- but not during ß2-AR stimulation.4 For ß1-AR–stimulated hearts, this led to PKA-dependent phosphorylation of the key regulatory proteins phospholamban, troponin I, and C protein and phosphorylation of the inactive b form of glycogen phosphorylase to the active a form. This suggested that the metabolic responses to ß1- and ß2-AR stimulation may differ. In particular, greater glycogenolysis may occur during ß1-AR than ß2-AR stimulation.4

We hypothesized that as a result of these differences in cAMP signaling, the relationship between cardiac contractile function and bioenergetics differs between ß1- and ß2-AR stimulation. Studies in the intact heart permit an evaluation of the working organ with accurate regulation of substrate and oxygen delivery without the complexity of other neurohumoral factors present in the whole organism.

31P NMR spectroscopy provides real-time measurements of the intracellular concentrations of phosphocreatine (PCr), ATP, and inorganic phosphate (Pi), as well as pH. Previous applications of this technique have been made to ß-adrenergic stimulation in isolated5–8 and in situ9,10 rat hearts, isolated guinea pig hearts,11 in situ rabbit hearts12 and human hearts,13,14 each demonstrating decreased PCr concentration, but without specifically addressing differences between ß1- and ß2-AR–mediated effects.

In the present study, we used 31P NMR spectroscopy, oxygen consumption measurements, and measurements of contractile function to establish relationships between bioenergetics and work in the isolated perfused rat heart during ß1- and ß2-AR stimulation, under both limiting and nonlimiting flow conditions.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Isolated Heart Preparation
Male Wistar rats (Charles River, Wilmington, Mass), 3 to 4 months of age, were injected with 20 mg/kg 6-hydroxydopamine 24 hours before experimentation to attenuate the effect of endogenous catecholamines.15 Hearts were rapidly excised under anesthesia; perfused through the aorta with a filtered (0.45 µm), warmed (37°C), and gassed (95% O2/5% CO2) buffer in a nonrecirculating system; and allowed to beat spontaneously. The buffer consisted of (in mmol/L) 118 NaCl, 5 KCl, 0.5 Na2EDTA, 1.2 MgSO4, 25 NaHCO3, 1.8 CaCl2, 11 glucose, and 1100 U/L heparin.

A water-filled polyethylene balloon connected to a pressure transducer was inserted into the left ventricle (LV) and used to measure the LV pressure. Balloon inflation was adjusted to achieve a preload of 10 to 15 mm Hg. RPP was used as an index of workload. To test the stability of the preparation, a control group of hearts (n=5) was perfused under constant perfusion pressure (CP) for 2 hours. During this time, LV developed pressure (LVDP), heart rate (HR), and PCr/Pi ratio remained within 11.5±4% of baseline.

M{image}O2 Measurements
An O2-sensitive fiber-optic fluorometer (Presens GmbH) was used to measure the O2 saturation in the arterial line and in the venous effluent via a cannula sutured into the coronary sinus. M{image}O2 was derived from the arteriovenous O2 difference per unit coronary flow.

31P NMR Spectroscopy
Perfused hearts were placed in a glass tube, then inserted into a 9.4-T Magnex magnet (Magnex Scientific) interfaced to a Bruker DMX spectrometer (Bruker Analytik GmbH). Shimming was performed to achieve a water proton line width of <=40 Hz. After a stabilization period, 31P spectra were acquired continuously over a period of 3 minutes using a pulse flip angle of 45°, repetition time of 1.5 seconds, spectral width of 12 kHz, 50-Hz line broadening, and zero filling to 8K points. A small tube containing 400 mmol/L methylenediphosphonate (MDP) was placed outside the heart and used as a chemical shift and signal intensity standard. Quantification was performed with Lorentzian deconvolution. The ratio of the PCr and Pi resonances was used as an index of the intracellular energy charge (IEC).16 Intracellular pH was calculated from the chemical shift difference between the PCr and Pi resonances.17

Experimental Protocols
Experiments were performed both under conditions of high constant flow (HCF) and CP. In the HCF experiments, the fixed flow rate (28.4±0.1 mL/min) was equal to the highest flow rates observed under CP (at the start of the perfusion) and is at the upper end of the range typically used in isolated rat heart perfusion experiments.

Under the CP protocol (CP=120 mm Hg), the coronary flow rate decreased over the duration of the experiment for both groups 1, 24%; ß2, 28%), with the respective coronary flow time courses not significantly different (P=0.3). Therefore, the CP protocol provided a convenient method for examining flow-limiting and hence oxygen-limiting conditions.

Under each protocol, hearts underwent either selective ß1-AR stimulation (ß1 group) or selective ß2-AR stimulation (ß2 group). The doses used were based on previous studies2,3 and are listed in the Table. Three 12-minute doses of increasing concentrations of the ß1 agonist norepinephrine or the ß2 agonist zinterol (Bristol-Myers Squibb) were administered to the ß1 and ß2 groups, respectively. To increase selectivity of the receptor stimulation, an {alpha}-AR antagonist, prazosin, or a ß1-AR antagonist, bisoprolol (Merck), was used for ß1 and ß2-stimulated hearts, respectively, in combination with the agonists.2,4 Figure 1 shows typical responses of RPP and M{image}O2 for a ß1- and a ß2-AR–stimulated heart during HCF at baseline and during each of the 3 doses. Typical 31P NMR spectra obtained during baseline and ß-AR stimulation are shown in Figure 2.


View this table:
[in this window]
[in a new window]
 
Dose Protocol Used After the 30-Minute Equilibration Period



View larger version (14K):
[in this window]
[in a new window]
 
Figure 1. RPP and M{image}O2 time-course data for a ß1- and a ß2-AR–stimulated heart.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. Typical examples of 31P NMR spectra during (A) baseline and (B) ß1-AR stimulation (10-7 mol/L norepinephrine), showing MDP, Pi, and PCr resonances and {gamma}-, {alpha}-, and ß-phosphate resonances of ATP. A decrease in PCr concentration and corresponding increase in Pi concentration occurs as predicted by creatine kinase and ATP hydrolysis equilibria. Note that ATP concentration remained relatively constant.

LVDP, HR, RPP, and M{image}O2 reached their maxima approximately 3 to 4 minutes after the beginning of each dose. The data from the last 8 minutes of each period were averaged to measure dose responses. The NMR-measured metabolite concentrations were assessed from an average over the last 3 of the 4 spectra acquired during each dose period. During the normal buffer and baseline antagonist periods, all parameters showed very little change, and averages were therefore taken over the entire duration of these periods.

Statistics
Data are reported as mean±SEM. The dose responses for coronary flow, LVDP, HR, PCr/Pi, M{image}O2, and pH were analyzed for main and interaction effects using repeated-measures ANOVA. Statistical comparisons of the bioenergetic-workload correlations between the ß1 and ß2 groups (for each protocol) and between the CP and HCF protocols (for each group) were made by use of ANCOVA and analyzed for main and interaction effects. A value of P<0.05 was considered to be statistically significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Dose Responses
Preliminary experiments using both perfusion protocols showed that the maximum agonist doses chosen elicited a near-maximal response in RPP. In particular, the larger range of RPPs achieved in response to ß1-AR stimulation could not be achieved during ß2-AR stimulation. The mean baseline values of all measured parameters were generally consistent between the ß1 and ß2 groups.

LV Developed Pressure
LVDP increased significantly in a dose-dependent manner in both groups (Figure 3A). Under HCF, the maximum response for the ß1 group (415% of baseline) was significantly greater than that of the ß2 group (158% of baseline). Under the flow-limiting CP protocol, the maximum ß1-AR–mediated LVDP response was only half that under HCF (187% of baseline), whereas the response of the ß2-AR–stimulated groups was similar to that under HCF (132% of baseline).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 3. Responses under CP and HCF plotted as percent of baseline for each perfusion period: (A) LVDP, (B) HR, (C) RPP, (D) M{image}O2, (E) PCr/Pi ratio, and (F) pH. Data are shown for ß1- (solid lines) and ß2-AR–stimulated hearts (dotted lines) and CP (circles) and HCF (squares). Where error bars are not visible, they fall within symbol area. ß1 group: CP, n=10; HCF, n=5, and ß2 group: CP, n=8; HCF, n=6. In all cases, a significant main effect of dose was found at P<0.05 level. *P<0.05 for responsexß-stimulation group interaction (for each protocol); {dagger}P<0.05 for responsexflow protocol interaction (for each group).

Heart Rate
Dose-dependent increases in HR were observed for each group (Figure 3B). The range of this response was somewhat greater during ß1-AR (141% of baseline) than during ß2-AR (124% of baseline) stimulation. No such difference was found under the CP protocol (134% and 132% of baseline for the ß1 and ß2 groups, respectively).

Rate-Pressure Product
The dose dependence of cardiac workload as measured by the RPP is shown in Figure 3C. For the ß1-AR–stimulated hearts, the workload was influenced predominantly by the LVDP response, leading to much greater RPPs at maximum dose (HCF, 575%; CP, 250%), compared with the ß2 group (HCF, 190%; CP, 172%).

Oxygen Consumption
M{image}O2 increased relative to baseline at all doses (Figure 3D) in both groups. During the HCF protocol, the ß1 group showed substantially greater maximum M{image}O2 response (241% of baseline) than the ß2 group (130% of baseline). Under the flow-limiting CP protocol, significantly lower maximal M{image}O2 was observed in the ß1 group only (ß1, 139%; ß2, 134%).

Intracellular Energy Charge
In the HCF protocol, the IEC (Figure 3E) decreased in a dose-dependent manner in both groups to similar final values (ß1, 36%; ß2, 45%). In the CP protocol, the dose dependence of this decrease was not significantly different for either the ß1-AR (P=0.2) or ß2-AR (P=0.8) group (IEC=51% and 41% at maximum dose, respectively).

pH
During HCF, significant acidosis occurred in the ß1-AR group only (Figure 3F). During CP, acidosis developed in both groups as a function of dose, although the pH reduction at maximum dose was greater in the ß1-AR group (HCF, 0.06; CP, 0.09).

Comparison of Bioenergetic Responses to ß1- and ß2-AR Stimulation
Substantially greater RPP dose responses were achieved during ß1-AR than during ß2-AR stimulation (HCF and CP), despite similar decreases in IEC (HCF and CP) and M{image}O2 (CP). We sought to determine the metabolic cost associated with a given workload during ß1- and ß2-AR stimulation by plotting IEC and M{image}O2 as functions of RPP. A significant difference in the IEC versus RPP relationship was observed under both HCF and CP (Figure 4), with ß2-AR stimulation resulting in a greater decrease in IEC as workload increased (CP, P=0.001; HCF, P=0.05).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 4. PCr/Pi vs rate-pressure product for ß1- and ß2-AR groups under (A) HCF and (B) CP. Each data point corresponds to average responses measured during baseline or 1 of 3 doses. This plot demonstrates response in PCr/Pi ratio (IEC) for a given RPP increase, removing dose dependence of specific agonists and concentrations that were used. Under conditions of both HCF and CP, for a given increase in RPP, ß2-AR–stimulated hearts show a significantly greater decrease (HCF, P=0.05; CP, P=0.001) in IEC than ß1-AR–stimulated hearts.

The slopes of the M{image}O2-RPP relationship (Figure 5) are indicative of the oxygen cost associated with a given RPP increase. During HCF, there was no significant difference in this relationship between the ß1 and ß2 groups (P=0.3). For the CP protocol, however, a significantly greater slope was observed in the ß2 group than in the ß1 group (P=0.05). Thus, under CP, although the maximal workload achieved under ß1 stimulation was much greater than under ß2 stimulation, maximal M{image}O2 was not significantly different between the 2 groups. However, the pH measurements (Figure 3F) indicate that these higher workloads were associated with significantly greater acidosis during ß1- than during ß2-AR stimulation.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 5. M{image}O2 vs rate-pressure product for ß1- and ß2-AR groups under (A) HCF and (B) CP. Each data point corresponds to average responses measured during baseline or 1 of 3 doses. During HCF (A), there is no subtype difference (P=0.3). During CP (B), however, for a given RPP increase, there is a significantly greater increase in oxygen consumption for ß2- than ß1-AR–stimulated hearts (P=0.05).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The major aim of this study was to compare the correlations between bioenergetics and LV workload during stimulation of ß1- and ß2-AR subtypes. Figure 6 is a schematic of the major factors that are expected to influence or regulate energy supply and demand and their interactions. The IEC can be viewed as an index of the supply:demand ratio, but alternatively as a regulator of the supply and demand, as depicted by the double-headed arrows (8 and 9) in Figure 6.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 6. Schematic showing major factors expected to influence energy supply and workload demand and hence intracellular energy charge during ß-adrenergic stimulation. Arrows and their directions show potential influences. Combination of our measurements under HCF and CP (flow-limiting) suggests that influences of certain factors shown in this figure are flow dependent, as indicated. Coronary flow can potentially be mediated via ß-AR stimulation (arrow 1), although our data showed no difference in flow between ß1 and ß2 groups. However, flow was clearly influenced by choice of perfusion protocol. ß1-AR–mediated activation of phosphorylase kinase can influence provision of endogenous glycogen as substrate (arrow 2). Total available substrate may then be utilized via aerobic (arrow 3) or anaerobic (arrow 4) pathways, providing energy supply. ß-AR workload response is mediated via increased Cai release and reuptake by sarcoplasmic reticulum (arrow 5). However, calcium ions act as dual messengers by also activating mitochondrial dehydrogenases, NAD-isocitrate, 2-oxoglutarate, and pyruvate dehydrogenase, thereby regulating generation of ATP by oxidative phosphorylation (arrow 6). Feedback is also regulated between workload and oxidative phosphorylation via phosphorylation potential [ATP/(ADPxPi)] and mitochondrial NADH/NAD ratio (arrow 7).

Greater Energy Availability and Contractile Response During ß1-AR Stimulation
During the CP protocol, we observed a far greater RPP response during ß1- than during ß2-AR stimulation. Despite this difference, the decrease in IEC was similar in the ß1- and ß2-AR–stimulated hearts (Figure 4B). This indicates a similar energy supply:demand ratio and therefore an increase in energy production commensurate with workload during ß1-AR stimulation. For ß1-AR stimulation, the increased flow (and therefore oxygen delivery) under the HCF protocol resulted in an almost 2-fold greater contractile response compared with the response under the flow-limiting CP protocol. For the ß2-AR–stimulated hearts, however, the responses under the 2 flow protocols were similar. This suggests that under the CP protocol, the maximal ß1-AR–mediated increases in workload were flow limited. Despite the very large difference in the maximum workload achieved during ß1- and ß2-AR stimulation with HCF, the net decrease in IEC was again similar (Figure 4A), implying that energy production was augmented during ß1-AR stimulation to meet the greater demand.

Increased Anaerobic Metabolism During ß1-AR Stimulation Under Oxygen-Limited Conditions
Under CP, the greater workload demand and energy production during ß1- compared with ß2-AR stimulation occurred without a large increase in oxygen requirements (Figure 5B). This suggests that during ß1-AR stimulation, anaerobic metabolism was used for this additional energy production. This is supported by the intracellular pH measurements (Figure 3F), which demonstrated significantly greater acidosis during the maximum response to ß1-AR stimulation, consistent with increased lactate production from glycolysis. In contrast, during HCF, the increased work achieved by ß1-AR stimulation was associated with a commensurate increase in M{image}O2 (Figure 5A) and a smaller degree of acidosis.

ß1-AR Stimulation Shows Increased IEC at a Given Workload
Our measurements allow us to examine a range of workloads common to both ß1- and ß2-AR–stimulated hearts and specifically the metabolic responses at a given workload during ß1- or ß2-AR stimulation. Under both flow protocols, at a fixed RPP, the IEC was preserved to a greater extent during ß1-AR stimulation (Figure 4), indicating that during ß1-AR stimulation there was greater energy reserve, consistent with increased energy production. Under CP, at a given RPP, a clear difference in the M{image}O2 was found between the ß1- and ß2-AR–stimulated hearts (Figure 5), a difference not present in the HCF protocol. This suggests that during ß1-AR stimulation under O2-limiting conditions, the increase in workload was facilitated by energy production through anaerobic pathways.

Regulation of Energy Charge and the Workload Response
Intracellular calcium ([Ca2+]i) levels are known to be greater during ß1-AR stimulation1–4 and may be a more significant regulator of oxidative phosphorylation (Figure 6, arrow 5) during ß1-AR stimulation than during ß2-AR stimulation. This regulation would be expected to be more effective when O2 is not limiting and is consistent with the greater augmentation of energy supply and workload demand during ß1-AR stimulation under HCF compared with that under CP. This could lead to more effective augmentation of the other regulators of oxidative phosphorylation, such as phosphorylation potential and mitochondrial NADH/NAD ratio (Figure 6, arrow 7), and ultimately to increased feedback between these regulators and cardiac workload. During ß2-AR stimulation, energy supply and demand regulation by [Ca2+], phosphorylation potential, and mitochondrial NADH/NAD ratio may be reduced, with a similar effect occurring under reduced flow during ß1-AR stimulation.

The M{image}O2 data and pH data under CP suggest that when oxygen limits the aerobic energy supply, anaerobic metabolism can be used during ß1-AR stimulation in conjunction with additional substrate delivery. When oxygen delivery is increased (HCF), [Ca2+]i regulation of oxidative phosphorylation could act in concert with the additional substrate to preserve the IEC, leading to the even larger workload responses.

At the maximum workloads achieved, there was no statistical difference in the IEC between the ß1 and ß2 groups during CP or HCF. This suggests that the energy supply:demand ratio was similar under these conditions of near maximal stimulation. This could indicate a lower limit for IEC, which might then limit the workload response. Alternatively, however, IEC can be thought of as an energy "reserve" that can be rapidly utilized after sudden increases in demand. In this context, this reserve may be "depleted" by workload to some limiting extent during maximal stimulation. The maintenance of this increased workload would then be regulated by energy supply through the usual aerobic and anaerobic pathways, which would in turn depend on both O2 and substrate supply.

Mechanisms for Increased Energy Charge
Although we cannot draw absolute conclusions about the origin of the additional energy available under ß1-AR stimulation, an attractive possibility is increased substrate supply from the breakdown of endogenous glycogen, followed by anaerobic and/or aerobic glucose metabolism. This is consistent with previous results demonstrating that glycogen phosphorylase kinase is activated during ß1- but not during ß2-AR stimulation.4 Glycogen availability under ß1-AR stimulation may be a result of specific signaling that leads to conversion of glycogen phosphorylase from the inactive b form to the active a form.

Significant reliance on glycogenolysis and subsequent glucose metabolism during epinephrine-induced mixed ß-adrenergic stimulation in the isolated heart has been observed with radiolabeling.18,19 However, epinephrine is a potent agonist for both the ß1- and ß2-AR subtypes. Our results suggest, for the first time, that reliance on an alternative energy source to meet requirements under ß-adrenergic stimulation occurs specifically under ß1-AR stimulation.

Although these results are consistent with glycogen being the origin of additional substrate available during ß1-AR stimulation, we cannot distinguish between this and the possibility of enhanced delivery of exogenous glucose, for example, via an unspecified ß1-AR–mediated activation of glucose transporters.

The M{image}O2 and pH differences between the ß1- and ß2-AR–stimulated hearts suggest that during the flow-limiting conditions of the CP experiments, a significant proportion of any potential additional substrate is metabolized anaerobically. Under HCF, the IEC data are still consistent with increased use of glycogen in the ß1 hearts, but the M{image}O2 and pH data suggest that given sufficient O2, this substrate is metabolized primarily aerobically.

Furthermore, it should be noted that the ß1-/ß2-AR differences in M{image}O2 and IEC are also consistent with increased oxidative efficiency during ß1-AR stimulation. This may result from decreased utilization of O2 for noncontractile cellular processes or futile cycles. This could result in greater preservation of IEC because of an effectively greater energy supply for contraction. However, other evidence suggests that the opposite may be true, namely, that ß1-AR stimulation is less energy efficient than ß2-AR stimulation. One possible mechanism that has been proposed for this is spontaneous [Ca2+]i oscillations during ß1-AR stimulation.3

Effect of Competing Substrates
In the intact organism, free fatty acids (FFAs) are the preferred substrate of the heart in the fasted state. However, it has been shown that under ß-AR–induced stress in the perfused rat heart, carbohydrates become the preferred substrate, with glucose and glycogen showing large increases in oxidation compared with relatively minor increases in oxidation of exogenous FFAs and endogenous triglycerides.20,21 Furthermore, the endogenous lipolytic capacity of the heart is considerably smaller than the capacity for glycogen mobilization and subsequent carbohydrate oxidation, which is directly regulated by mitochondrial feedback. Therefore, we expect that metabolism of exogenous FFAs and endogenous triglycerides would make only a minor contribution to the observed differences between ß1- and ß2-AR stimulation.

Summary
We have demonstrated for the first time, in a working heart preparation, a difference in metabolic response to ß1- and ß2-AR stimulation. These differences are consistent with differences in energy supply, possibly mediated by ß-AR subtype–dependent endogenous substrate utilization. These metabolic differences may underlie the large differences in ß1- and ß2-AR–mediated functional responses.

Received December 9, 2002; accepted January 14, 2003.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Xiao RP, Cheng H, Zhou YY, et al. Recent advances in cardiac ß2-adrenergic signal transduction. Circ Res. 1999; 85: 1092–1100.[Abstract/Free Full Text]

2. Xiao RP, Hohl C, Altschuld R, et al. ß2-Adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem. 1994; 269: 19151–19156.[Abstract/Free Full Text]

3. Xiao RP, Lakatta EG. ß1-Adrenoceptor stimulation and ß2-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca2+, and Ca2+ current in single rat ventricular cells. Circ Res. 1993; 73: 286–300.[Abstract/Free Full Text]

4. Kuschel M, Zhou YY, Spurgeon HA, et al. ß2-Adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation. 1999; 99: 2458–2465.[Abstract/Free Full Text]

5. Matthews PM, Williams SR, Seymour AM, et al. A 31P-NMR study of some metabolic and functional effects of the inotropic agents epinephrine and ouabain, and the ionophore R02-2985 (X537A) in the isolated, perfused rat heart. Biochim Biophys Acta. 1982; 720: 163–171.[Medline] [Order article via Infotrieve]

6. Headrick JP, Willis RJ. Effect of inotropic stimulation on cytosolic Mg2+ in isolated rat heart: a 31P magnetic resonance study. Magn Reson Med. 1989; 12: 328–338.[Medline] [Order article via Infotrieve]

7. Headrick JP, Willis RJ. Adenosine formation and energy metabolism: a 31P-NMR study in isolated rat heart. Am J Physiol. 1990; 258: H617–H624.[Medline] [Order article via Infotrieve]

8. Kupriyanov VV, Korchazhkina OV, Lakomkin VL. Regulation of cardiac energy turnover by coronary flow: a 31P-NMR study. J Mol Cell Cardiol. 1993; 25: 1235–1247.[CrossRef][Medline] [Order article via Infotrieve]

9. Bittl JA, Balschi JA, Ingwall JS. Effects of norepinephrine infusion on myocardial high-energy phosphate content and turnover in the living rat. J Clin Invest. 1987; 79: 1852–1859.[Medline] [Order article via Infotrieve]

10. Headrick JP, Dobson GP, Williams JP, et al. Bioenergetics and control of oxygen consumption in the in situ rat heart. Am J Physiol. 1994; 267: H1074–H1084.[Medline] [Order article via Infotrieve]

11. He MX, Wangler RD, Dillon PF, et al. Phosphorylation potential and adenosine release during norepinephrine infusion in guinea pig heart. Am J Physiol. 1987; 253: H1184–H1191.[Medline] [Order article via Infotrieve]

12. Headrick JP, Emerson CS, Berr SS, et al. Interstitial adenosine and cellular metabolism during beta-adrenergic stimulation of the in situ rabbit heart. Cardiovasc Res. 1996; 31: 699–710.[CrossRef][Medline] [Order article via Infotrieve]

13. Lamb HJ, Beyerbacht HP, Ouwerkerk R, et al. Metabolic response of normal human myocardium to high-dose atropine-dobutamine stress studied by 31P-MRS. Circulation. 1997; 96: 2969–2977.[Abstract/Free Full Text]

14. Pluim BM, Lamb HJ, Kayser HW, et al. Functional and metabolic evaluation of the athlete’s heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation. 1998; 97: 666–672.[Abstract/Free Full Text]

15. Boluyt MO, Younes A, Caffrey JL, et al. Age-associated increase in rat cardiac opioid production. Am J Physiol. 1993; 265: H212–H218.[Medline] [Order article via Infotrieve]

16. Gadian DG, Radda GK. NMR studies of tissue metabolism. Annu Rev Biochem. 1981; 50: 69–83.[CrossRef][Medline] [Order article via Infotrieve]

17. Gupta RK, Wittenberg BA. 31P-NMR studies of isolated adult heart cells: effect of myoglobin inactivation. Am J Physiol. 1991; 261: H1155–H1163.[Medline] [Order article via Infotrieve]

18. Goodwin GW, Ahmad F, Taegtmeyer H. Preferential oxidation of glycogen in isolated working rat heart. J Clin Invest. 1996; 97: 1409–1416.[Medline] [Order article via Infotrieve]

19. Goodwin GW, Ahmad F, Doenst T, et al. Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts. Am J Physiol. 1998; 274: H1239–H1247.[Medline] [Order article via Infotrieve]

20. Collins-Nakai RL, Noseworthy D, Lopaschuk GD. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. Am J Physiol. 1994; 267: H1862–H1871.[Medline] [Order article via Infotrieve]

21. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem. 1998; 273: 29530–29539.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. McConville, E. G. Lakatta, and R. G. Spencer
Greater glycogen utilization during 1- than 2-adrenergic receptor stimulation in the isolated perfused rat heart
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1828 - E1835.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Boudina, S. Sena, B. T. O'Neill, P. Tathireddy, M. E. Young, and E. D. Abel
Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in Obesity
Circulation, October 25, 2005; 112(17): 2686 - 2695.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. McConville, R. G. Spencer, and E. G. Lakatta
Temporal dynamics of inotropic, chronotropic, and metabolic responses during {beta}1- and {beta}2-AR stimulation in the isolated, perfused rat heart
Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E412 - E418.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/16/2146    most recent
01.CIR.0000062686.72615.9Bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McConville, P.
Right arrow Articles by Spencer, R. G.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McConville, P.
Right arrow Articles by Spencer, R. G.S.
Related Collections
Right arrow Contractile function
Right arrow Biochemistry and metabolism
Right arrow Cardiovascular Pharmacology
Right arrow Other diagnostic testing